|
Volumn 32 Suppl 2, Issue , 2009, Pages
|
A summary of the ADVANCE Trial.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
GLYCOSYLATED HEMOGLOBIN;
INSULIN;
METFORMIN;
SULFONYLUREA DERIVATIVE;
ARTICLE;
DIABETIC ANGIOPATHY;
DIABETIC RETINOPATHY;
DISEASE COURSE;
DRUG EFFECT;
GLUCOSE BLOOD LEVEL;
HUMAN;
METABOLISM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
VASCULAR DISEASE;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
DIABETIC RETINOPATHY;
DISEASE PROGRESSION;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
METFORMIN;
OVERWEIGHT;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK FACTORS;
SULFONYLUREA COMPOUNDS;
VASCULAR DISEASES;
|
EID: 75549087054
PISSN: None
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc09-s339 Document Type: Article |
Times cited : (87)
|
References (0)
|